Literature DB >> 7608688

Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype.

G Kaplanski, F Retornaz, J Durand, J Soubeyrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7608688      PMCID： PMC1073567          DOI： 10.1136/jnnp.58.6.758-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

Review 1.  Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years.

Authors:  F E Shaw; D J Graham; H A Guess; J B Milstien; J M Johnson; G C Schatz; S C Hadler; J N Kuritsky; E E Hiner; D J Bregman
Journal:  Am J Epidemiol       Date:  1988-02       Impact factor: 4.897

2.  Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.

Authors:  L Herroelen; J de Keyser; G Ebinger
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

Review 3.  Immunization of adults.

Authors:  P Gardner; W Schaffner
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245
  3 in total
  4 in total

Review 1.  Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.

Authors:  Yahel Segal; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

Review 2.  Safety of routine childhood vaccinations. An epidemiological review.

Authors:  R T Chen; G Mootrey; F DeStefano
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

3.  Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.

Authors:  Dominique Le Houézec
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

4.  Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis.

Authors:  Andreas Rogalewski; Jörg Kraus; Martin Hasselblatt; Christoffer Kraemer; Wolf-Rüdiger Schäbitz
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.